Does SIMVASTATIN Cause Interstitial lung disease? 172 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Interstitial lung disease have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.6% of all adverse event reports for SIMVASTATIN.
172
Reports of Interstitial lung disease with SIMVASTATIN
0.6%
of all SIMVASTATIN reports
11
Deaths
93
Hospitalizations
How Dangerous Is Interstitial lung disease From SIMVASTATIN?
Of the 172 reports, 11 (6.4%) resulted in death, 93 (54.1%) required hospitalization, and 19 (11.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for SIMVASTATIN.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SIMVASTATIN Alternatives Have Lower Interstitial lung disease Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS